Corbus Pharmaceuticals Holdings, Inc. (CRBP)
NASDAQ: CRBP · Real-Time Price · USD
18.68
+0.37 (2.02%)
Nov 5, 2024, 11:12 AM EST - Market open
CRBP Employees
Corbus Pharmaceuticals Holdings had 19 employees as of December 31, 2023. The number of employees decreased by 14 or -42.42% compared to the previous year.
Employees
19
Change (1Y)
-14
Growth (1Y)
-42.42%
Revenue / Employee
n/a
Profits / Employee
-$1,840,543
Market Cap
224.98M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Inogen | 834 |
Lifecore Biomedical | 524 |
Molecular Partners AG | 168 |
Kyverna Therapeutics | 96 |
Solid Biosciences | 88 |
XBiotech | 82 |
PepGen | 64 |
Eton Pharmaceuticals | 30 |
CRBP News
- 7 days ago - Corbus Pharmaceuticals to Present at the Guggenheim Securities Healthcare Innovation Conference - GlobeNewsWire
- 20 days ago - Corbus Announces Enrollment Completion of Dose Escalation Stage of Phase 1 Clinical Trial of Its Next Generation Nectin-4 Targeting ADC (CRB-701) - GlobeNewsWire
- 5 weeks ago - Corbus Pharmaceuticals to Participate in the BMO Capital Markets' Oncology Summit - GlobeNewsWire
- 6 weeks ago - Nasdaq-Traded Cannabinoid Biotech Corbus Pharma Stock Plunges 60%, But Analysts Say 'Buy The Dip' Now - Benzinga
- 2 months ago - Obesity drugs' next wave: These companies could snag 20% of GLP-1 market, analysts say - Market Watch
- 2 months ago - Corbus Pharmaceuticals Strengthens Board of Directors with Appointment of Winston Kung - GlobeNewsWire
- 3 months ago - Corbus Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Corporate Update - GlobeNewsWire
- 3 months ago - Corbus Pharmaceuticals to Participate in Upcoming Investor Conferences in August - GlobeNewsWire